Analyst Ratings January 27, 2026

Evercore ISI Affirms Outperform on Texas Instruments, Sees 15% Upside

Analyst firm highlights positioning, potential data-center share gains and margin tailwinds while noting valuation and near-term growth moderation

By Marcus Reed TXN
Evercore ISI Affirms Outperform on Texas Instruments, Sees 15% Upside
TXN

Evercore ISI has reaffirmed an Outperform rating on Texas Instruments with a $226 price target, implying roughly 15% upside from the current $196.59 share price. The research note cites investor underweighting in analog and microcontroller chips ahead of fourth-quarter earnings, the potential for data-center market share gains in 2026, and an upcoming Capital Management Day webinar as constructive catalysts, while flagging valuation and near-term revenue growth moderation as offsets.

Key Points

  • Evercore ISI reaffirms Outperform on Texas Instruments with a $226 price target, implying about 15% upside from the current $196.59 share price.
  • Analysts cite underweight positioning in analog/microcontroller semiconductors, potential 2026 data-center market share gains, and an upcoming Capital Management Day webinar as supportive catalysts; TXN has a $178.6 billion market capitalization.
  • Stifel maintains a Hold rating with a $200 target, expects $4.40 billion in revenue and $1.27 non-GAAP EPS for the upcoming quarter; Texas Instruments declared a $1.42 quarterly dividend payable Feb 10, 2026 to holders of record on Jan 30, 2026.

Evercore ISI has reiterated an Outperform rating on Texas Instruments Inc. with a price objective of $226.00, which the firm says represents about 15% upside from the prevailing share price of $196.59.

The research note points to several factors supporting the bullish stance. Evercore ISI highlights that many investors remain underweight exposure to analog and microcontroller semiconductor names heading into fourth-quarter earnings, a positioning that could create upside should actual results surprise. The firm also flagged expectations that Texas Instruments could secure meaningful additional market share in the data-center segment in 2026, an outcome that would be constructive for long-term growth prospects.

Texas Instruments is identified in the report as a significant industry participant, with a market capitalization of $178.6 billion in the Semiconductors & Semiconductor Equipment sector. Evercore ISI observed that over the past six months the stock has underperformed the S&P 500 by roughly five percentage points and has lagged the semiconductor index (SOX) by about 35 percentage points during the same interval, suggesting room for relative recovery if industry dynamics shift favorably.

Among potential catalysts, the analyst note flags an upcoming Capital Management Day webinar as an event that could signal improved gross margins into 2027 as depreciation expense declines. Evercore ISI also referenced generally positive feedback from industry contacts regarding the company. The company’s long-running dividend record was noted as another investor-friendly attribute: Texas Instruments has paid dividends for 56 consecutive years and currently yields 2.89%, per InvestingPro figures cited in the note.

Evercore ISI balanced those positives against several cautionary items. The firm observed that Texas Instruments outperformed the S&P 500 by 4% over the most recent week, which could temper near-term upside. Additionally, the company’s price-to-earnings multiple stands at a 39% absolute premium and a 15% relative premium versus the median P/E since 2012, signaling a rich valuation on certain measures. The note also expects year-over-year revenue growth to decelerate to 11% from 14% in the first quarter, indicating a potential slowdown in top-line momentum.

Separately, Stifel has maintained a Hold rating on Texas Instruments and set a $200 price target. In its outlook, Stifel expects the company to meet a revenue estimate of $4.40 billion for the upcoming quarter, which would represent a 7.3% decline from the prior quarter, and to deliver non-GAAP earnings per share of $1.27. Stifel also lifted its price target from $170 to $200, citing signs of a cyclical recovery and growth across all end markets.

On shareholder returns, Texas Instruments declared a quarterly dividend of $1.42 per share that will be payable on February 10, 2026 to holders of record as of January 30, 2026.

In product news, the company introduced a new family of automotive semiconductors, the TDA5 system-on-chip line, targeting enhanced vehicle safety and autonomy. Evercore ISI’s note describes the TDA5 family as providing edge artificial intelligence acceleration with performance in the range of 10 to 1,200 trillion operations per second and power efficiency exceeding 24 TOPS per watt. The chips are positioned to support up to Level 3 autonomous driving capability.

Collectively, the Evercore ISI report frames a mix of strategic opportunities and valuation-related constraints for Texas Instruments heading into upcoming earnings and corporate events. The firm’s Outperform rating and $226 target rest on a combination of potential market-share gains, margin tailwinds from depreciation rolling off, and a long-standing dividend profile, while also acknowledging nearer-term growth moderation and a premium valuation.


Bottom line: Evercore ISI’s reiteration of an Outperform rating underscores confidence in Texas Instruments’ longer-term prospects, even as valuation and revenue-growth pacing pose immediate considerations for investors.

Risks

  • Valuation appears elevated - TXN’s P/E shows a 39% absolute and 15% relative premium versus median P/E since 2012, which could limit upside if earnings do not expand as expected. (Impacts technology and equity markets.)
  • Near-term revenue growth is expected to slow to 11% year-over-year from 14% in the first quarter, representing a potential deceleration in top-line momentum. (Impacts semiconductor sector and corporate earnings forecasts.)
  • Short-term price moves may be mixed - the stock outperformed the S&P 500 by 4% in the past week but has underperformed broader indexes over six months, introducing uncertainty in timing of any recovery. (Impacts investor positioning and portfolio allocation within tech equities.)

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026